Nippon Chemiphar Parts Ways With Ranbaxy; Takes Over Generics Venture

Tokyo-based Nippon Chemiphar Dec. 8 announced a dissolution of its partnership with India's Ranbaxy Laboratories. A generic drug joint venture established by the two will become a Nippon Chemiphar wholly owned subsidiary

More from Archive

More from Scrip